South Dakota Clinical Trials

Recruiting studies in South Dakota

• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellAberdeen, SD
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerRapid City, SD
• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  NCT06966700PHASE3Merck Sharp & Dohme LLCBreast NeoplasmsSioux Falls, SD
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652PHASE3AstraZenecaHeart Failure and Impaired Kidney FunctionRapid City, SD
• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
  NCT07630974PHASE1, PHASE2Merck Sharp & Dohme LLCMalignant NeoplasmSioux Falls, SD
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisSioux Falls, SD
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803PHASE3AstraZenecaWeight ManagementRapid City, SD
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
  NCT06541704PHASE3Regeneron PharmaceuticalsAge-related Macular Degeneration (AMD)Rapid City, SD
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseSioux Falls, SD
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058PHASE3Hoffmann-La RocheObesity or OverweightSioux Falls, SD
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerSioux Falls, SD
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967PHASE3Bristol-Myers SquibbPlaque PsoriasisRapid City, SD

See all 254 recruiting trials →

Popular conditions in South Dakota

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in South Dakota?

Corterve aggregates actively recruiting clinical trials with sites in South Dakota from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in South Dakota free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in South Dakota?

South Dakota research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.